Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Integra Lifesciences Holdings (IART) Invested Capital (2016 - 2025)

Integra Lifesciences Holdings (IART) has disclosed Invested Capital for 17 consecutive years, with $1.8 billion as the latest value for Q4 2025.

  • Quarterly Invested Capital fell 23.23% to $1.8 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.8 billion through Dec 2025, down 23.23% year-over-year, with the annual reading at $1.8 billion for FY2025, 23.23% down from the prior year.
  • Invested Capital hit $1.8 billion in Q4 2025 for Integra Lifesciences Holdings, roughly flat from $1.8 billion in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $2.6 billion in Q4 2022 to a low of $1.8 billion in Q4 2025.
  • Historically, Invested Capital has averaged $2.3 billion across 5 years, with a median of $2.4 billion in 2021.
  • Biggest five-year swings in Invested Capital: increased 9.64% in 2021 and later decreased 23.23% in 2025.
  • Year by year, Invested Capital stood at $2.5 billion in 2021, then grew by 2.01% to $2.6 billion in 2022, then fell by 8.39% to $2.4 billion in 2023, then dropped by 2.42% to $2.3 billion in 2024, then fell by 23.23% to $1.8 billion in 2025.
  • Business Quant data shows Invested Capital for IART at $1.8 billion in Q4 2025, $1.8 billion in Q3 2025, and $1.8 billion in Q2 2025.